- PLx Pharma press release ( NASDAQ: PLXP ): Q3 GAAP EPS of -$0.30.
- Revenue of $0.39M (-94.1% Y/Y).
For further details see:
PLx Pharma GAAP EPS of -$0.30, revenue of $0.39MFor further details see:
PLx Pharma GAAP EPS of -$0.30, revenue of $0.39MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
SPARTA, N.J., April 12, 2023 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ and VAZALORE ® ,...
SPARTA, N.J., April 11, 2023 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potential to...
2023-04-11 06:00:00 ET 3 Tips for Finding Winning Penny Stocks in 2023 The potential for exponential growth has made penny stocks a favorite among investors seeking to capitalize on undervalued, up-and-coming companies. Penny stocks , typically defined as those trading below $5 per ...